Free Trial

Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Choate Investment Advisors

Mettler-Toledo International logo with Medical background
Remove Ads

Choate Investment Advisors reduced its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 16.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,197 shares of the medical instruments supplier's stock after selling 433 shares during the period. Choate Investment Advisors' holdings in Mettler-Toledo International were worth $2,688,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp raised its stake in Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier's stock valued at $1,431,693,000 after buying an additional 9,009 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier's stock valued at $818,906,000 after acquiring an additional 4,166 shares during the last quarter. Principal Financial Group Inc. raised its position in shares of Mettler-Toledo International by 13.9% during the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier's stock worth $335,977,000 after acquiring an additional 33,456 shares in the last quarter. Barclays PLC lifted its stake in Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier's stock worth $384,822,000 after purchasing an additional 19,609 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after purchasing an additional 28,478 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Remove Ads

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares of the company's stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now owns 734 shares of the company's stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Citigroup reduced their price target on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an "equal weight" rating in a report on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a "peer perform" rating on the stock. Finally, Evercore ISI raised their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $1,380.50.

Get Our Latest Analysis on Mettler-Toledo International

Mettler-Toledo International Stock Down 1.6 %

NYSE MTD traded down $20.11 during trading hours on Thursday, hitting $1,200.33. 120,915 shares of the stock were exchanged, compared to its average volume of 138,095. The company has a market cap of $25.11 billion, a price-to-earnings ratio of 29.62, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12-month low of $1,142.91 and a 12-month high of $1,546.93. The stock has a 50-day moving average of $1,293.93 and a 200 day moving average of $1,313.29.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, equities research analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge
Google’s $32B Move: 3 Cybersecurity Stocks to Watch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads